Zantac & Ranitidine Lawsuit
Cancer-causing substance found in heartburn drugs.
Zantac and its generic, ranitidine, have been found to contain the cancer-causing chemical NDMA (N-nitrosodimethylamine). This chemical is used in gasoline, rocket fuel, as a stabilizer in industrial materials, and as an additive to lubricants.
Zantac is sold by the manufacturer Sanofi, as well as generically under the name ranitidine.
Lawsuits filed against the manufacturer maintain that Zantac contains levels of NDMA that are 26,000 times higher than the levels allowed by the FDA. In the recent past, several blood pressure medications that were found to contain the cancer-causing chemical NDMA were recalled from the market.
What is Zantac?
Ranitidine (also known by its brand name Zantac) is a medication that is used to decrease stomach acid production. It is commonly used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome.
Zantac Possible Side Effects
According to the National Institutes of Health (NIH), people taking ranitidine medications may experience the following side effects:
- chest pain not associated with
- heartburn
- constipation
- dark urine
- diarrhea
- headache
- nausea
- shortness of breath
- stomach pain
- vomiting
Linked to Cancer
According to studies of the contaminant NDMA (N-nitrosodimethylamine), possible side effects of ingestion of Zantac/ranitidine are:
- bladder cancer
- stomach cancer
- esophageal cancer
- liver cancer
- pancreatic cancer